IL-33 or anti-CSF1R alone could control the tumor volume and tumor weight, whereas the combination of IL-33 and anti-CSF1R showed a further antitumor effect in the subcutaneous MFC-challenged 615-line mouse model (Appendix Fig. S9A,B). The gene discussed is CSF1R; the disease is neoplasm.